These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6735459)

  • 1. Cardiovascular hemodynamics and vasopressin blockade in DOCA-salt hypertensive rats.
    Yamamoto J; Yamane Y; Umeda Y; Yoshioka T; Nakai M; Ikeda M
    Hypertension; 1984; 6(3):397-407. PubMed ID: 6735459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs.
    Liard JF
    Circ Res; 1986 May; 58(5):631-40. PubMed ID: 3754791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac hypertrophy developing during DOCA-salt treatment is dissociated from systemic and regional hemodynamics.
    Kobrin I; Eimerl J; Mekler J; Ben-Ishay D
    Am J Hypertens; 1990 Feb; 3(2):136-9. PubMed ID: 2137702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and regional hemodynamic effects of endogenous vasopressin stimulation in rats.
    Charocopos F; Hatzinikolaou P; North WG; Gavras H
    Am J Physiol; 1982 Oct; 243(4):H560-5. PubMed ID: 7124963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
    Kohlmann O; Ginoza M; Cezaretti ML; Zanella MT; Ribeiro AB; Tavares A; Ramos OL; Leeman SE; Gavras I; Gavras H
    Hypertension; 1995 Dec; 26(6 Pt 2):1186-9. PubMed ID: 7498993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of hypertonic saline in the conscious rat.
    Garcia-Estañ J; Carbonell LF; Garcia-Salom M; Salazar FJ; Quesada T
    Life Sci; 1989; 44(19):1343-50. PubMed ID: 2566102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
    Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
    Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of stroma-free hemoglobin and diaspirin cross-linked hemoglobin on the regional circulation and systemic hemodynamics.
    Gulati A; Sharma AC; Burhop KE
    Life Sci; 1994; 55(10):827-37. PubMed ID: 8072379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension.
    Filep J; Frölich JC; Fejes-Toth G
    Clin Exp Hypertens A; 1985; 7(10):1457-70. PubMed ID: 3841034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex.
    Rascher W; Lang RE; Taubitz M; Meffle H; Unger T; Ganten D; Gross F
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():153s-156s. PubMed ID: 7188584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoconstrictor role for vasopressin in conscious, sodium-depleted rats.
    Jover B; Dupont M; Mimran A; Woods R; McGrath B
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H763-9. PubMed ID: 2889370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
    Stone CK; Liang CS; Imai N; Sakamoto S; Sladek CD; Hood WB
    Circulation; 1988 Nov; 78(5 Pt 1):1251-9. PubMed ID: 3180381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats.
    Osborn JW; Skelton MM; Cowley AW
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H628-37. PubMed ID: 3826404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute interaction of vasopressin and neurogenic mechanisms in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H37-43. PubMed ID: 7058911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs.
    Rose CE; Godine RL; Rose KY; Anderson RJ; Carey RM
    J Clin Invest; 1984 Aug; 74(2):321-31. PubMed ID: 6547729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.